MELINDA ZYCH: Open Payments
NPI 1528425659 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,243 in 54 payments from 9 companies in 2025. Trend: 2023 $1,118 · 2024 $1,211 · 2025 $1,243
Food & beverage: $1,243
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $837 |
| Teva Pharmaceuticals USA, Inc. | 3 | $135 |
| Neurocrine BioSciences, Inc. | 4 | $94 |
| JAZZ PHARMACEUTICALS INC. | 2 | $50 |
| Neurelis, Inc. | 2 | $38 |
| PFIZER INC. | 2 | $36 |
| LivaNova USA, Inc. | 1 | $18 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: QULIPTA, UBRELVY, AUSTEDO XR, INGREZZA, BOTOX, VRAYLAR, EPIDIOLEX, VALTOCO.
Industry payments across MO — which companies pay providers there.
